Matching articles for "clobazam"
Issue 1709 · August 19, 2024
Ganaxolone (Ztalmy) for CDKL5 Deficiency Disorder (online only)

The FDA has approved ganaxolone ( Ztalmy – Marinus) for oral treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder in patients ≥2 years old. It is the first drug…

Med Lett Drugs Ther. 2024 Aug 19; 66(1709):e139-40 doi:10.58347/tml.2024.1709g
The FDA has approved ganaxolone ( Ztalmy – Marinus) for oral treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder in patients ≥2 years old. It is the first drug to be approved in the US for this indication.
Issue 1708 · August 5, 2024
Comparison Table: Some Oral Antiseizure Medications (online only)

View the Comparison Table: Some Oral Antiseizure Medications

Med Lett Drugs Ther. 2024 Aug 5; 66(1708):e133-40 doi:10.58347/tml.2024.1708b
View the Comparison Table: Some Oral Antiseizure Medications
Issue 1708 · August 5, 2024
Drugs for Epilepsy

When used for the appropriate seizure type, antiseizure medications (ASMs) are roughly equivalent in efficacy. In addition to the seizure type, the choice of drug is usually based on factors such as ease of…

Med Lett Drugs Ther. 2024 Aug 5; 66(1708):121-8 doi:10.58347/tml.2024.1708a
When used for the appropriate seizure type, antiseizure medications (ASMs) are roughly equivalent in efficacy. In addition to the seizure type, the choice of drug is usually based on factors such as ease of use, spectrum of activity, adverse effects, interactions with other drugs, presence of comorbid conditions, suitability for elderly persons and those with childbearing potential, and cost. Treatment should begin with a single drug, increasing the dosage gradually until seizures are controlled or adverse effects become unacceptable. If seizures persist, expert clinicians generally try at least one and sometimes a second alternative drug as monotherapy before considering use of two drugs at the same time.
Issue 1630 · August 9, 2021
Fenfluramine (Fintepla) for Dravet Syndrome

The FDA has approved fenfluramine oral solution ( Fintepla – Zogenix) for treatment of seizures in patients ≥2 years old with Dravet syndrome. It is the third drug to be approved for this indication.…

Med Lett Drugs Ther. 2021 Aug 9; 63(1630):126-8
The FDA has approved fenfluramine oral solution ( Fintepla – Zogenix) for treatment of seizures in patients ≥2 years old with Dravet syndrome. It is the third drug to be approved for this indication. Stiripentol (Diacomit) and cannabidiol (Epidiolex) , a purified product derived from marijuana, were approved earlier.
Issue 1620 · March 24, 2021
Stiripentol (Diacomit) for Dravet Syndrome (online only)

The FDA has approved stiripentol (Diacomit – Biocodex) for treatment of seizures in patients ≥2 years old with Dravet syndrome who are also taking clobazam (Onfi) . Stiripentol, which has been available in…

Med Lett Drugs Ther. 2021 Mar 24; 63(1620):e1-3
The FDA has approved stiripentol (Diacomit – Biocodex) for treatment of seizures in patients ≥2 years old with Dravet syndrome who are also taking clobazam (Onfi) . Stiripentol, which has been available in Europe, Canada, and Japan for many years, is the second drug to be approved in the US for this indication; cannabidiol oral solution (Epidiolex) , a purified marijuana product, was the first.
Issue 1610 · November 2, 2020 Free
In Brief: New Benzodiazepine Warnings

The FDA now requires boxed warnings in the package inserts of benzodiazepines describing the potential for these drugs to be abused and misused and to cause addiction and physical dependence. Benzodiazepine…

Med Lett Drugs Ther. 2020 Nov 2; 62(1610):175
The FDA now requires boxed warnings in the package inserts of benzodiazepines describing the potential for these drugs to be abused and misused and to cause addiction and physical dependence. Benzodiazepine labels have contained a boxed warning about a risk of serious drug interactions with opioids since 2016.
Issue 1585 · November 18, 2019
Cannabis and Cannabinoids

Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of…

Med Lett Drugs Ther. 2019 Nov 18; 61(1585):179-82
Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce intoxication or euphoria.
Issue 1559 · November 5, 2018
Cannabidiol (Epidiolex) for Epilepsy

The FDA has approved cannabidiol oral solution ( Epidiolex – Greenwich Biosciences) for treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in patients ≥2 years old.…

Med Lett Drugs Ther. 2018 Nov 5; 60(1559):182-4
The FDA has approved cannabidiol oral solution ( Epidiolex – Greenwich Biosciences) for treatment of seizures associated with Dravet syndrome or Lennox-Gastaut syndrome in patients ≥2 years old. Cannabidiol (CBD) is a cannabinoid constituent of the marijuana plant (Cannabis sativa) . It is the first natural marijuana product to be approved by the FDA for any indication and the first drug to be approved in the US for treatment of Dravet syndrome. Stiripentol (Diacomit) , which is not a marijuana product, was also recently approved by the FDA for treatment of Dravet syndrome in combination with clobazam ( Onfi) and will be reviewed in a future issue.
Issue 1526 · July 31, 2017
Drugs for Epilepsy

Treatment of epilepsy should begin with a single antiepileptic drug (AED), increasing its dosage gradually until seizures are controlled or adverse effects become intolerable. If seizures persist, specialists…

Med Lett Drugs Ther. 2017 Jul 31; 59(1526):121-30
Treatment of epilepsy should begin with a single antiepileptic drug (AED), increasing its dosage gradually until seizures are controlled or adverse effects become intolerable. If seizures persist, specialists generally recommend trying at least one and sometimes a second alternative drug as monotherapy before considering use of two drugs concurrently. When used for the appropriate seizure type, AEDs are roughly equivalent in efficacy. Drug choice is usually based on factors such as ease of use, adverse effects, drug interactions, presence of comorbidities, and cost.
Issue 1526 · July 31, 2017
Comparison Table: Some Oral Antiepileptic Drugs (online only)

View the Comparison Table: Some Oral Antiepileptic Drugs

Med Lett Drugs Ther. 2017 Jul 31; 59(1526):e130-6
View the Comparison Table: Some Oral Antiepileptic Drugs
Issue 126 · February 1, 2013
Drugs for Epilepsy

Treatment of epilepsy should begin with a single drug, increasing the dosage gradually until seizures are controlled or adverse effects become unacceptable. If seizures persist, expert clinicians generally…

Treat Guidel Med Lett. 2013 Feb; 11(126):9-18
Treatment of epilepsy should begin with a single drug, increasing the dosage gradually until seizures are controlled or adverse effects become unacceptable. If seizures persist, expert clinicians generally prescribe at least one and sometimes a second alternative drug as monotherapy before considering use of two drugs at the same time. When used for the appropriate seizure type, antiepileptic drugs are roughly equivalent in efficacy. The choice of drug is usually based on factors such as ease of use, adverse effects, interactions with other drugs, presence of comorbid conditions and cost.
Issue 1385 · March 5, 2012
Clobazam (Onfi) for Lennox-Gastaut Syndrome

Clobazam ( Onfi – Lundbeck), an oral benzodiazepine, has been approved by the FDA for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients ≥2 years old. It has been…

Med Lett Drugs Ther. 2012 Mar 5; 54(1385):18-9
Clobazam ( Onfi – Lundbeck), an oral benzodiazepine, has been approved by the FDA for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients ≥2 years old. It has been available in Canada (Frisium) and other countries for years for treatment of anxiety and many types of epilepsy.